AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple Sclerosis
Status:
Unknown status
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Patients with marked bladder dysfunction as a result of secondary progressive multiple
sclerosis are being recruited to receive AIMSPRO or placebo by subcutaneous injection, in
this double-blind crossover study.